tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRISM Therapeutics Begins GMP Production of ChemoSeed for Glioblastoma Trial
Company AnnouncementsCRISM Therapeutics Begins GMP Production of ChemoSeed for Glioblastoma Trial
13d ago
CRISM Therapeutics Announces AGM and New Incentive Plan
PremiumCompany Announcements
CRISM Therapeutics Announces AGM and New Incentive Plan
20d ago
CRISM Therapeutics Announces Change in Major Holdings
PremiumCompany Announcements
CRISM Therapeutics Announces Change in Major Holdings
2M ago
CRISM Therapeutics Raises £874,021 to Advance Cancer Treatment Technology
PremiumCompany Announcements
CRISM Therapeutics Raises £874,021 to Advance Cancer Treatment Technology
2M ago
CRISM Therapeutics Updates Investors on Funding and Future Plans
PremiumCompany Announcements
CRISM Therapeutics Updates Investors on Funding and Future Plans
2M ago
CRISM Therapeutics Advances Glioblastoma Treatment with Phase 2 Trial
PremiumCompany AnnouncementsCRISM Therapeutics Advances Glioblastoma Treatment with Phase 2 Trial
2M ago
CRISM Therapeutics Launches Retail Offer to Fund ChemoSeed Development
Premium
Company Announcements
CRISM Therapeutics Launches Retail Offer to Fund ChemoSeed Development
2M ago
CRISM Therapeutics Secures £800,000 for Glioblastoma Drug Trials
Premium
Company Announcements
CRISM Therapeutics Secures £800,000 for Glioblastoma Drug Trials
2M ago
CRISM Therapeutics Reports Significant Progress and Strategic Milestones
PremiumCompany Announcements
CRISM Therapeutics Reports Significant Progress and Strategic Milestones
2M ago
CRISM Therapeutics Wins Prestigious Award for ChemoSeed Research
PremiumCompany Announcements
CRISM Therapeutics Wins Prestigious Award for ChemoSeed Research
3M ago
CRISM Therapeutics Forms Scientific Advisory Board for Glioblastoma Trial
PremiumCompany Announcements
CRISM Therapeutics Forms Scientific Advisory Board for Glioblastoma Trial
3M ago
CRISM Director Increases Stake in Company
PremiumCompany Announcements
CRISM Director Increases Stake in Company
5M ago
CRISM Therapeutics Advances ChemoSeed Trials with MHRA Support
PremiumCompany AnnouncementsCRISM Therapeutics Advances ChemoSeed Trials with MHRA Support
5M ago
CRISM Therapeutics Secures Innovate UK Grant for Prostate Cancer Treatment Development
Premium
Company Announcements
CRISM Therapeutics Secures Innovate UK Grant for Prostate Cancer Treatment Development
5M ago
CRISM Therapeutics Partners with Aixial Group for Phase 2 Glioblastoma Trial
Premium
Company Announcements
CRISM Therapeutics Partners with Aixial Group for Phase 2 Glioblastoma Trial
8M ago
CRISM Therapeutics Secures European Patent for Innovative Brain Tumor Treatment
PremiumCompany Announcements
CRISM Therapeutics Secures European Patent for Innovative Brain Tumor Treatment
8M ago
CRISM Therapeutics Reports Positive Interim Results
PremiumCompany Announcements
CRISM Therapeutics Reports Positive Interim Results
11M ago
CRISM Therapeutics to Reveal Mid-Year Results
PremiumCompany Announcements
CRISM Therapeutics to Reveal Mid-Year Results
12M ago
CRISM’s ChemoSeed Validated for Glioma Treatment
PremiumCompany Announcements
CRISM’s ChemoSeed Validated for Glioma Treatment
12M ago
CRISM Therapeutics Earns MHRA Innovation Passport
PremiumCompany AnnouncementsCRISM Therapeutics Earns MHRA Innovation Passport
12M ago
CRISM Therapeutics Secures Lucrative Biotech Contract
Premium
Company Announcements
CRISM Therapeutics Secures Lucrative Biotech Contract
1y ago
CRISM Therapeutics Share Price Surges Unexpectedly
Premium
Company Announcements
CRISM Therapeutics Share Price Surges Unexpectedly
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >